Improving COVID-19 vaccine response in individuals receiving methotrexate

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{613877ca85774fb5a9f89b3b79ac2efb,

title = "Improving COVID-19 vaccine response in individuals receiving methotrexate",

author = "Katie Bechman and James Galloway",

year = "2024",

month = feb,

doi = "10.1016/S2665-9913(23)00306-5",

language = "English",

volume = "6",

pages = "e67--e68",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Improving COVID-19 vaccine response in individuals receiving methotrexate

AU - Bechman, Katie

AU - Galloway, James

PY - 2024/2

Y1 - 2024/2

UR - http://www.scopus.com/inward/record.url?scp=85180329251&partnerID=8YFLogxK

U2 - 10.1016/S2665-9913(23)00306-5

DO - 10.1016/S2665-9913(23)00306-5

M3 - Comment/debate

AN - SCOPUS:85180329251

SN - 2665-9913

VL - 6

SP - e67-e68

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 2

ER -